Sekri Valentin Zerrouk advised QIMA in connection with the acquisition of OxiProteomics by its QIMA Life Sciences division
The M&A department of Sekri Valentin Zerrouk advised QIMA in connection with the acquisition of OxiProteomics by QIMA Life Sciences. OxiProteomics specializes in the discovery of biomarkers related to aging, age-related diseases, and oxidative stress in biological samples.
Team
Other transactions
-
Corporate
![]()
Advising the management team of Magellan Partners in connection with the arrival of ICG as a new partner
-
Corporate
![]()
Advising Upciti in a $20M Series A round led by Notion Capital
-
Corporate
![]()
Advising Isentroniq in a €7.5M fundraising round
-
Corporate
![]()
Advising Turenne Hôtellerie on the acquisition of the four-star Novotel Centre Gare Cité des Congrès hotel in Nantes
-
Corporate
![]()
Advising Goodvest in a €12M Series B funding round
-
Corporate
![]()
Advising GENEO Capital, Bpifrance and Rives Croissance as part of the sale of ConvictionsRH
-
Real estate law
![]()
Advising Bang & Olufsen in the negotiation of a commercial lease for its new flagship store in Paris
-
Corporate
![]()
Advising Genomines on the connection with a $45 million Series A financing
-
Corporate
![]()
Advising Valtus in connection with the acquisition of FS Partners in Switzerland
-
Corporate
![]()
Advising Turenne Hôtellerie in connection with the sale of the Hôtel Mercure Nice Centre Notre Dame, in Nice
